ALL KEYWORDS
Gastric (stomach) Cancer Genomics
Related Specialists
Showing 3 of 30
Related Clinical Trials
Showing 2 of 9
PROgram to address psychosocial Support, clinical outcomes, and genomic insights for Patients with EaRly onset cancers
- Colorectal Cancer
- Sarcoma Cancers
- Stomach & Esophagus
- Kidney Cancer
- Head & Neck Cancers
- Liver Cancer
- Lung Cancer
- Gynecological Cancers
- Pancreatic Cancer
- Prostate Cancer
- Thyroid & Other Endocrine Cancers
- Breast Cancer
Beamion BCGC-1: A Phase Ib Dose Escalation and Phase II Dose Optimization, Randomized, Open-label, Multicenter Trial of Oral Zongertinib (BI 1810631) in Combination With Intravenous Trastuzumab Deruxtecan (T-DXd) or in Combination With Intravenous Trastuzumab Emtansine (T-DM1) for Treatment of Patients With Advanced HER2+ Metastatic Breast Cancer (mBC) and Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (mGEAC)
- Phase 1 Cancers
